Engineered bacteria reprogram tumor microenvironment via cell senescence and neutrophil extracellular traps
Wanfa Dong1, Chenyang Li2, Jiqiang Lu1
1School of Biopharmacy, China Pharmaceutical University, Nanjing 211198, China.
Abstract:
Attenuated Salmonella VNP20009 (VNP) shows promising anti-cancer therapeutic potential. Limited understanding of its anti-tumor mechanism has hindered broader clinical application. Recent studies have reported cellular senescence is involved in tumor progression; however, its critical role in VNP therapy remains elusive. Our study revealed that VNP exerts anti-tumor growth and anti-angiogenesis effects by inducing cellular senescence in tumor cells and vascular endothelial cells. While VNP-induced senescence inhibits tumor growth, it concurrently promotes neutrophil extracellular traps (NETs), which paradoxically enhance tumor progression. To address this challenge, we engineered VNP-SNase, a novel variant capable of releasing the DNA-degrading enzyme Staphylococcus aureus nuclease directly within tumors. VNP-SNase significantly inhibited NETs formation across multiple tumor types, effectively promoted anti-tumor immunity, and exhibited improved tumor suppression effects with enhanced biosafety. Our findings elucidate the critical role of cellular senescence in VNP therapy and propose targeting NETs as a strategic approach to enhance the efficacy of VNP-based cancer treatments.
Insights
Attenuated Salmonella (VNP) shows anti-cancer promise by inducing cellular senescence. A new VNP variant, VNP-SNase, targets neutrophil extracellular traps (NETs), enhancing anti-tumor immunity and improving cancer treatment safety and efficacy.
Area of Science:
- Oncology
- Microbiology
- Immunology
Background:
- Attenuated Salmonella VNP20009 (VNP) exhibits anti-cancer properties.
- The precise anti-tumor mechanisms of VNP, particularly the role of cellular senescence, require further elucidation.
- Cellular senescence is implicated in tumor progression, but its specific involvement in VNP therapy is unclear.
Purpose of the Study:
- To investigate the role of cellular senescence in VNP-mediated anti-tumor effects.
- To explore the paradoxical role of VNP-induced senescence in promoting neutrophil extracellular traps (NETs).
- To engineer a VNP variant (VNP-SNase) to overcome NETs-mediated tumor promotion and enhance anti-cancer efficacy.
Main Methods:
- Utilized attenuated Salmonella VNP20009 for anti-tumor studies.
- Investigated VNP-induced cellular senescence in tumor and vascular endothelial cells.
- Engineered VNP-SNase to release Staphylococcus aureus nuclease for DNA degradation.
- Assessed NETs formation, anti-tumor immunity, and tumor suppression in various tumor models.
Main Results:
- VNP induced cellular senescence, leading to anti-tumor growth and anti-angiogenesis.
- VNP-induced senescence promoted NETs formation, paradoxically enhancing tumor progression.
- VNP-SNase effectively inhibited NETs formation across multiple tumor types.
- VNP-SNase demonstrated enhanced anti-tumor immunity and improved tumor suppression with better biosafety.
Conclusions:
- Cellular senescence plays a critical role in VNP therapy, with both beneficial and detrimental effects.
- Targeting NETs formation is a crucial strategy to enhance the efficacy of Salmonella-based cancer therapies.
- VNP-SNase represents a promising next-generation therapeutic agent for cancer treatment.
Related Concept Videos
The Tumor Microenvironment
The Tumor Microenvironment
Replicative Cell Senescence
Tumor Immunotherapy
Targeted Cancer Therapies
There are several types of targeted therapies against...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...


